Skip to main content
logo
Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
1,094.10
-17.70 (-1.59%)
Jun 1, 2026, 3:29 PM IST

Strides Pharma Science Revenue

In the fiscal year ending March 31, 2026, Strides Pharma Science had annual revenue of 48.59B INR with 6.43% growth. Strides Pharma Science had revenue of 13.23B in the quarter ending March 31, 2026, with 11.18% growth.

Revenue
48.59B
Revenue Growth
+6.43%
P/S Ratio
2.11
Revenue / Employee
14.72M
Employees
3,301
Market Cap
102.48B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202648.59B2.93B6.43%
Mar 31, 202545.65B6.75B17.36%
Mar 31, 202438.90B2.02B5.47%
Mar 31, 202336.88B6.18B20.13%
Mar 31, 202230.70B-2.46B-7.41%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma88.69B
Alembic Pharmaceuticals73.45B
NATCO Pharma43.76B
Akums Drugs and Pharmaceuticals43.59B
Eris Lifesciences31.15B
Alivus Life Sciences25.52B
Cohance Lifesciences22.69B
Aarti Pharmalabs18.29B
Revenue Rankings

Strides Pharma Science News

More News